Dmitry V Chistyakov1, Nadezhda V Azbukina2,3, Alina A Astakhova2, Sergei V Goriainov4, Viktor V Chistyakov4, Veronika V Tiulina2, Viktoriia E Baksheeva2, Vladislav I Kotelin5, Elena V Fedoseeva5, Andrey A Zamyatnin2,6, Pavel P Philippov2, Olga A Kiseleva5, Alexander M Bessmertny5, Ivan I Senin2, Elena N Iomdina5, Marina G Sergeeva2, Evgeni Yu Zernii7,8. 1. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 1-40 Leninskye Gory, Moscow, Russia, 119992. chistyakof@gmail.com. 2. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 1-40 Leninskye Gory, Moscow, Russia, 119992. 3. Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia, 119234. 4. Peoples' Friendship University of Russia, Moscow, Russia, 117198. 5. Helmholtz National Medical Research Center of Eye Diseases, Moscow, Russia, 105062. 6. Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia, 119991. 7. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 1-40 Leninskye Gory, Moscow, Russia, 119992. zerni@belozersky.msu.ru. 8. Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia, 119991. zerni@belozersky.msu.ru.
Abstract
INTRODUCTION: Ocular inflammation is a key pathogenic factor in most blindness-causing visual disorders. It can manifest in the aqueous humor (AH) and tear fluid (TF) as alterations in polyunsaturated fatty acids (PUFAs) and their metabolites, oxylipins, lipid mediators, which are biosynthesized via enzymatic pathways involving lipoxygenase, cyclooxygenase or cytochrome P450 monooxygenase and specifically regulate inflammation and resolution pathways. OBJECTIVES: This study aimed to establish the baseline patterns of PUFAs and oxylipins in AH and TF by their comprehensive lipidomic identification and profiling in humans in the absence of ocular inflammation and comparatively analyze these compounds in the eye liquids of rabbits, the species often employed in investigative ophthalmology. METHODS: Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used for qualitative and quantitative characterization of lipid compounds in the analyzed samples. RESULTS: A total of 28 lipid compounds were identified, including phospholipid derivatives and PUFAs, as well as 22 oxylipins. Whereas the PUFAs included arachidonic, docosahexaenoic and eicosapentaenoic acids, the oxylipins were derived mainly from arachidonic, linoleic and α-linolenic acids. Remarkably, although the concentration of oxylipins in AH was lower compared to TF, these liquids showed pronounced similarity in their lipid profiles, which additionally exhibited noticeable interspecies concordance. CONCLUSION: The revealed correlations confirm the feasibility of rabbit models for investigating pathogenesis and trialing therapies of human eye disorders. The identified metabolite patterns suggest enzymatic mechanisms of oxylipin generation in AH and TF and might be used as a reference in ocular inflammation studies.
INTRODUCTION:Ocular inflammation is a key pathogenic factor in most blindness-causing visual disorders. It can manifest in the aqueous humor (AH) and tear fluid (TF) as alterations in polyunsaturated fatty acids (PUFAs) and their metabolites, oxylipins, lipid mediators, which are biosynthesized via enzymatic pathways involving lipoxygenase, cyclooxygenase or cytochrome P450 monooxygenase and specifically regulate inflammation and resolution pathways. OBJECTIVES: This study aimed to establish the baseline patterns of PUFAs and oxylipins in AH and TF by their comprehensive lipidomic identification and profiling in humans in the absence of ocular inflammation and comparatively analyze these compounds in the eye liquids of rabbits, the species often employed in investigative ophthalmology. METHODS: Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used for qualitative and quantitative characterization of lipid compounds in the analyzed samples. RESULTS: A total of 28 lipid compounds were identified, including phospholipid derivatives and PUFAs, as well as 22 oxylipins. Whereas the PUFAs included arachidonic, docosahexaenoic and eicosapentaenoic acids, the oxylipins were derived mainly from arachidonic, linoleic and α-linolenic acids. Remarkably, although the concentration of oxylipins in AH was lower compared to TF, these liquids showed pronounced similarity in their lipid profiles, which additionally exhibited noticeable interspecies concordance. CONCLUSION: The revealed correlations confirm the feasibility of rabbit models for investigating pathogenesis and trialing therapies of humaneye disorders. The identified metabolite patterns suggest enzymatic mechanisms of oxylipin generation in AH and TF and might be used as a reference in ocular inflammation studies.
Authors: Damiana Pieragostino; Michele D'Alessandro; Maria di Ioia; Carmine Di Ilio; Paolo Sacchetta; Piero Del Boccio Journal: Proteomics Clin Appl Date: 2015-01-12 Impact factor: 3.494
Authors: Lloyd W Sumner; Alexander Amberg; Dave Barrett; Michael H Beale; Richard Beger; Clare A Daykin; Teresa W-M Fan; Oliver Fiehn; Royston Goodacre; Julian L Griffin; Thomas Hankemeier; Nigel Hardy; James Harnly; Richard Higashi; Joachim Kopka; Andrew N Lane; John C Lindon; Philip Marriott; Andrew W Nicholls; Michael D Reily; John J Thaden; Mark R Viant Journal: Metabolomics Date: 2007-09 Impact factor: 4.290
Authors: Scott D Walter; Karsten Gronert; Allison L McClellan; Roy C Levitt; Konstantinos D Sarantopoulos; Anat Galor Journal: Invest Ophthalmol Vis Sci Date: 2016-05-01 Impact factor: 4.799
Authors: Evgeni Yu Zernii; Aliya A Nazipova; Ekaterina L Nemashkalova; Alexey S Kazakov; Olga S Gancharova; Marina V Serebryakova; Natalya K Tikhomirova; Viktoriia E Baksheeva; Vasiliy I Vladimirov; Dmitry V Zinchenko; Pavel P Philippov; Ivan I Senin; Sergei E Permyakov Journal: Front Mol Neurosci Date: 2019-01-07 Impact factor: 5.639
Authors: Hannah M Terhaar; Michala de Linde Henriksen; Lisa K Uhl; Corey Boeckling; Carolina Mehaffy; Ann Hess; Michael R Lappin Journal: PLoS One Date: 2022-08-23 Impact factor: 3.752
Authors: Dmitry V Chistyakov; Olga S Gancharova; Viktoriia E Baksheeva; Veronika V Tiulina; Sergei V Goriainov; Nadezhda V Azbukina; Marina S Tsarkova; Andrey A Zamyatnin; Pavel P Philippov; Marina G Sergeeva; Ivan I Senin; Evgeni Yu Zernii Journal: Biomedicines Date: 2020-09-11